Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Sees Success In $2 Billion Sales Goal For China, India, Brazil

This article was originally published in PharmAsia News

Executive Summary

U.S. drug maker Merck says its plan to realize $2 billion in sales in China, India and Brazil is on track because its drugs match major needs in all three. CEO Richard Clark said Merck is expanding manufacturing capacity to produce more vaccines, even in the face of competition from generics. Clark said the firm has done so because it focuses on the needs of patients and doctors in those countries. He said its best sellers in the three countries are its vaccines and drugs to treat diabetes and HIV, the major health problems in the three. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts